DataMeds AI, Inc.
DataMeds AI, Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||
Assets Current | ||||||||||||
Cash And Cash Equivalents At Carrying Value | 2 | 0 | 0 | 4 | 0 | 3 | 1 | |||||
Accounts Receivable Net Current | 1 | 1 | - | - | - | - | - | |||||
Inventory Net | 2 | 2 | 2 | 7 | 9 | 10 | 10 | |||||
Prepaid Expense Current | - | - | - | 0 | 0 | 0 | 0 | |||||
Deferred Costs Current | - | - | - | - | - | - | 1 | |||||
Other Receivables Net Current | 0 | 0 | - | - | - | - | - | |||||
Assets Current | 6 | 3 | 3 | 13 | 14 | 17 | 15 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Capitalized Computer Software Net | 2 | 2 | 2 | 2 | 2 | - | 2 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |||||
Goodwill | 14 | 14 | 14 | 16 | 16 | 16 | 16 | |||||
Other Intangible Assets Net | 10 | 10 | 10 | 18 | 19 | 20 | 21 | |||||
Notes And Loans Receivable Net Noncurrent | - | - | - | 0 | 0 | 0 | 0 | |||||
Equity Method Investments | - | - | - | - | - | 0 | 0 | |||||
Other Assets Noncurrent | - | - | - | 1 | 1 | 1 | 1 | |||||
Deposits Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 33 | 30 | 30 | 53 | 54 | 58 | 57 | |||||
Liabilities And Stockhold… | ||||||||||||
Liabilities Current | ||||||||||||
Accrued Liabilities And Other Liabilities | 7 | 4 | 6 | 5 | 5 | 5 | 4 | |||||
Other Short Term Borrowings | - | - | - | 4 | - | - | - | |||||
Convertible Debt Current | 12 | 7 | - | - | - | - | - | |||||
Secured Debt Current | 7 | 9 | 11 | 12 | 13 | 18 | 12 | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Current | 39 | 32 | 30 | 33 | 42 | 46 | 38 | |||||
Long Term Loans Payable | - | - | - | - | - | - | 0 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities | 52 | 45 | 43 | 46 | 53 | 54 | 51 | |||||
Stockholders Equity | ||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | - | 104 | 99 | 90 | 50 | 47 | 16 | |||||
Retained Earnings Accumulated Deficit | -137 | -119 | -111 | -83 | -49 | -42 | -10 | |||||
Stockholders Equity | -20 | -15 | -12 | 7 | 1 | 4 | 7 | |||||
Liabilities And Stockholders Equity | 33 | 30 | 30 | 53 | 54 | 58 | 57 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 3 | 2 | 2 | 2 | 1 | 1 | 1 | |||||
Shares Outstanding | 3 | 2 | 2 | 2 | 1 | 1 | 1 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -58.57% | -63.45% | - | - | - | - | - | - | - | - | - | - |
| 2025 | -33.98% | -64.45% | -67.19% | 72.41% | -24.25% | -26.55% | -1.11% | -32.13% | -46.14% | -12.41% | -38.54% | -36.50% |
| 2024 | - | - | - | - | - | - | - | - | - | -21.48% | -43.68% | -68.26% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
DataMeds AI, Inc. (MEDS) — SEC Financial Statements & Analysis
DataMeds AI, Inc. (MEDS) is a wholesale-drugs, proprietaries & druggists' sundries company, incorporated in DE. DataMeds AI, Inc. trades on Nasdaq as: MEDS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), DataMeds AI, Inc. reported a Gross Profit Margin of -90.64% (TTM), a Debt-to-Equity ratio of -2.68x, a Price-to-Sales (P/S) ratio of 0.99x (TTM), a Price-to-Book (P/B) ratio of -0.41x (TTM), at a market cap of $7.98M. Figures below are sourced from SEC EDGAR, as-filed.
- Gross Profit Margin TTM
- -90.64%
- Debt To Equity
- -2.68x
- P/S TTM
- 0.99x
- P/B TTM
- -0.41x
- Market Cap
- $7.98M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is DataMeds AI, Inc. in?
DataMeds AI, Inc. (MEDS) operates in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry.
What is MEDS's market cap?
DataMeds AI, Inc. (MEDS) has a market capitalization of $7.98M as of 2026-06-30.
What exchange does MEDS trade on?
DataMeds AI, Inc. (MEDS) trades on the Nasdaq.
Where is DataMeds AI, Inc. incorporated?
DataMeds AI, Inc. is incorporated in DE.